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A novel ligand bearing a central piperidinyl sulfonamide group, N(SO
2





pip)dpa)]+, have been synthesized in good yield. The methylene CH
2
signal seen as a singlet (4.54 ppm) in a 1H
NMR spectrumof the ligand inDMSO-𝑑
6





complex and confirms the presence ofmagnetically nonequivalent protons upon coordination to Re. Structural results revealed that
theRe–Nbond lengths fall within the normal range establishing coordination of ligand tometal.Thepresence of intraligand𝜋 → 𝜋∗
and 𝑛 → 𝜋∗ transitions is indicated by the absorption peaks around 200–250 nm in UV-visible spectra. Absorption peaks in UV-
visible spectra around 300 nm for metal complexes were identified as MLCT transitions.The S–N stretch observed as a strong peak
at 923 cm−1 for N(SO
2





The intense fluorescence displayed by the N(SO
2
pip)dpa ligand has quenched upon coordination to Re. Relatively low IC
50
values given by human breast cancer cells, MCF-7, (N(SO
2
















L complexes have provided a good
model system to interpret the nature of its analogous







]+ precursormay be easily utilized [1] for the
synthesis of new organometallic complexes having suitable
pharmaceutical properties. Furthermore, the triaquatricar-
bonyl complex of 99mTc, which is the group seven congener
of rhenium, is commercially available as a kit preparation [2],
enabling the easy simulation of the nonradioactive rhenium
complexes [3]. The use of nonradioactive rhenium facilitates
the synthesis of the metal complexes rather than handling
radioactive metal tracers.
Metal complexes (M = 99mTc, Re) bearing symmetrical
linear tridentate ligands have been reported to possess lower
bioaccumulation than complexes bearing bidentate or mon-
odentate ligands [2], resulting in fewer side effects when used
on the long term. Rhenium, in its lowest oxidation state,
is less sensitive to chemical attack by the reactive species
that may be present in cellular environment [2]. Facially
arranged carbonyl ligands cover one face of the distorted
octahedral complex thus protecting the metal center. Metal
carbon bonds are greatly stabilized by strong backdonation
from the carbonyl ligand to the metal. As rhenium is a soft
metal center, it prefers soft donors such as nitrogen and
tridentate metal complexes with nitrogen donors are widely
used [2, 4, 5].
Hindawi Publishing Corporation
Bioinorganic Chemistry and Applications
Volume 2016, Article ID 2675937, 10 pages
http://dx.doi.org/10.1155/2016/2675937



































Among various types of chronic human diseases, certain
types of cancers are widely treated by organometallic com-
plexes [6, 7]. Breast cancer is one of the most abundant types
of cancer in recent times. However, only a few metallophar-
maceuticals are available for diagnostic and therapeutic
purposes for human breast cancer [7, 8].
Sigma receptors are a distinct class of proteins that
are mostly found in the central nervous system [9]. Sigma
receptors are virtually absent in healthy human breast cells;
however, they appear in a high density in breast tumor
biopsy tissue [9, 10]. Proliferative human breast cancer cells
express approximately ten times more sigma receptors per
cell than the quiescent cells [9]. Therefore, high densities
of sigma receptors in rapidly proliferating breast cancer
cells make them ideal candidates for diagnosis as well as
therapy of breast cancer. Due to the multiple binding sites
containing lipophilic sterol binding domains on the protein
molecule, various types of exogenous ligands, such as several
derivatives of piperidine, piperazine [11, 12], benzamides
[13], and alkylamine [14], have been reported as potential
pharmaceuticals for therapy of human breast cancer, mainly
because these types of compounds preferentially bind with
sigma receptors [10].
To the best of our knowledge, there are only a few
radiotracers in which the piperidinyl group has been uti-
lized towards targeting sigma receptors; Satpati et al. have
synthesized 99mTc based cancer diagnostic agents [10], Choi
et al. have developed a 99mTc labeled sigma-2 receptor-
specific ligand as a potential breast tumor imaging agent [9],
and Caveliers et al. have utilized N-[2-(1󸀠-piperidinyl)ethyl]-
3-123I-iodo-4-methoxybenzamide [8]. Only the latter has
entered clinical trials for the diagnosis of patients with
primary breast cancer.
We based our study on the fact that fac-
[Re(CO)
3
(N(R)dpa)]+ complexes have been reported to
possess promising biomedical properties where R equals
a suitable substituent linked by a N–C bond at the central
nitrogen in dipicolylamine [15]. Furthermore, the tertiary
sulfonamide linkage has recently been utilized to propose a
new approach to radiopharmaceutical bioconjugation [5].
We also envisage that the target specificity may be increased
by incorporating a piperidinyl derivative into the novel
compounds.
Our goal has been to synthesize a novel ligand and its
rhenium tricarbonyl complex having possible therapeutic
potential, with the long term goal of extending this study
to 99mTc complexes towards the eventual diagnosis of breast
cancer. Thus, in this study we report the synthesis and char-
acterization of a novel piperidinyl appended dipicolylamine
ligand and its corresponding Re tricarbonyl complex and
go one step further to report their potential applicability in
biological systems as anticancer agents (Scheme 1).
2. Experimental





1-sulfonyl chloride, di(2-picolyl)amine, NaBF
4
, anhydrous
sodium sulphate, acetone, methanol, dichloromethane, chro-
masolv water, and dioxane were obtained from Sigma
Aldrich, USA. Human breast cancer cell line MCF-7 was
obtained from American Type Culture Collection. All the
solvents and chemicals were of analytical grade andwere used
as received, without further purification.
2.2. NMR Measurements. 1H NMR spectra were recorded
in DMSO-𝑑
6
on a Bruker 400MHz spectrometer. Peak
positions are relative to trimethylsilane (TMS) as reference.
All NMR data were processed with TopSpin 3.2 andMestReC
software.
2.3. X-Ray Data Collection and Structure Determination.
Single crystals were placed in a cooled nitrogen gas
stream at 90K on a Bruker Kappa Apex-II DUO diffrac-
tometer equipped with Cu K𝛼 (𝜆 = 1.54178>) radiation
(N(SO
2








performed by full-matrix least squares methods using
SHELXL (Sheldrick (2008)) [16], with H atoms in idealized
positions. Molecular graphics are drawn using ORTEP-3 for
windows [17].
2.4. UV-Visible Spectroscopy. Electronic spectra for ligand
and metal complex were obtained on Spectro UV-VIS
autoversion 3.10, UV-2602 spectrophotometer. The spec-
tral range was 190 nm–1100 nm. Spectra were obtained in
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methanol with base line correction. Spectral data were pro-
cessed with UVWIN software.
2.5. FTIR Analysis. FTIR spectra were recorded on aThermo
Scientific Nicolet iS10 spectrophotometer. ATR spectra were
obtained within the 4000–600 cm−1 spectral range. Spectral
data were processed with OMNIC software.
2.6. Fluorometric Analysis. Excitation and emission spectra
for ligand andmetal complex were obtained in methanol and
acetonitrile on aThermo Scientific Lumina spectrophotome-
ter. A 150W Xenon lamp was used as the excitation source.
Spectral data were processed with Luminous software.
















pip)dpa Ligand. A solution of piperidine-1-
sulfonyl chloride (0.034 g, 5mmol) in 25mL of dioxane was
added dropwise over a period of 2 hours to a solution of
N(H)dpa (0.057 g, 10mmol) in 100mL of dioxane at 20∘C.
The reaction mixture was stirred at room temperature for 24
hours and then filtered to remove any precipitate. Thereafter,
the dioxane was completely removed by rotary evaporation.
Slightly acidic water (30mL, pH ∼ 5) was added to the










washed with water (2 × 25mL), and taken to dryness. Grey
color, plate-like crystals were obtained. 1H NMR signals
(ppm) in DMSO-𝑑
6
are 8.49(d, 2H, H6/H6󸀠), 7.75(t, 2H,
H4/H4󸀠), 7.35(d, 2H, H3/H3󸀠), 7.27(t, 2H, H5/H5󸀠), 4.53(s,
2CH
2










pip)dpa (0.0346 g, 0.1mmol) in 3mL methanol







4mL). Methanol (3mL) was added to dissolve the precipitate
which formed. Acidity of the solution was measured (pH ∼
6) and the clear solution was heated at reflux for 16 h. A slight
excess of NaBF
4
was added to the clear, brownish yellow color
solution. The solution was then allowed to develop crystals
over three days at room temperature after which block-like,
colorless crystals were obtained. 1H NMR signals (ppm) in
DMSO-𝑑
6
are 8.84(d, 2H, H6/H6󸀠), 8.06(t, 2H, H4/H4󸀠),
7.61(d, 2H, H3/H3󸀠), 7.47(t, 2H, H5/H5󸀠), 5.39(d, endo-H),
5.01(d, exo-H), 3.68(s, 2H, Ha), and 1.68(s, 2H, Hb).
2.8. Biological Assays
2.8.1. Cytotoxicity Assessment. The novel ligand and its metal
complexwere investigated for their cytotoxicity againstMCF-
7 (breast cancer) cells. Cells were cultured in 96-well cul-
ture plates and exposed to 25 𝜇g/mL, 50 𝜇g/mL, 100𝜇g/mL,
200𝜇g/mL, and 400 𝜇g/mL concentrations of ligand and
complex for 24 h, 48 h, and 72 h, respectively, and cytotoxicity
was assessed by Sulforhodamine B assay [18]. All exposures
were carried out in triplicate. Briefly, the cell supernatant
was completely removed and washed with phosphate buffer
solution. Trichloroacetic acid (50%, 25 𝜇L) was added on
top of fetal bovine serum-free fresh medium (200𝜇L) to
make final concentration of 10% trichloroacetic acid and
was incubated at 4∘C for one hour former to the SRB assay.
The plate was then washed with five washing cycles with
water and dried completely. An aliquot of 100 𝜇L of 0.4%
Sulforhodamine B dissolved in 1% trichloroacetic acid, was
added to each well, and was allowed to stain for 15 minutes.
The plate was again washed with five washing cycles to
remove unbound dye using 1% (vol/vol) acetic acid after
removing the stain. The protein bound dye was solubilized
with trisbase (10mM, pH 7.5, 200𝜇L), after air-drying. The
plates were then shaken for 60 minutes to homogenize the
dye solution. The absorbance was then measured at 540 nm
using Synergy HTBioTek microplate reader. The percentage
viability was calculated by the equation given below:
Viable cell (%) = Absorbance of treated cells
Absorbance of untreated cells
× 100.
(1)
3. Results and Discussion
3.1. Structural Results. Crystal data and details of







pip)dpa)]+ are summarized in Table 1.
Crystallographic data are deposited with the Cambridge
Crystallographic Data Centre under deposition numbers
CCDC 1495607 and 1495608.
The uncoordinated ligand (Figure 1) possesses S–N(2)
bond length of 1.6194 (11) Å (Table 2). However, upon forming
the metal complex, the S–N(2) bond length has increased
(1.777 (2) Å). This may be attributed to the donation of
lone electron pair on sulfonamide nitrogen to Re, which
results in lowering of the strength of the S–N bond. Previous
studies have reported that the S–N distance is ∼1.73–1.76 Å
[5] when Re–N(sulfonamide) bond is strong [19]. The above
observation provides evidence that the complexation of the
ligandwith Re has occurred successfully.Weakly coordinated
or noncoordinated sulfonamide groups have considerable
double character. This is because of the conjugation of lone




pip)dpa ligand, planar geometry is observed
atN2 nitrogenwhich is sp2 hybridized.Therefore, C6, C7, and
S species are oriented in an angle of ∼120∘ to the central N2
(Table 3). All the other bond angles of the ligand lie within





pip)dpa)]+ complex, the coordi-
nation geometry at Re exhibits a pseudo octahedral structure
(Figure 1). This deviation may be due to the facial arrange-
ment of tridentate chelating unit which leads to forming two
strained, five-membered rings at Re resulting in a N–Re–N
bond angle < 90∘. The remaining three coordination sites of
4 Bioinorganic Chemistry and Applications






































Crystal system Triclinic Monoclinic




𝑎 (Å) 8.6557 (3) 10.8932 (4)
𝑏 (>) 10.1132 (3) 11.7517 (5)
𝑐 (>) 10.4022 (3) 20.7973 (8)
𝛼 (deg) 71.979 (1) —
𝛽 (deg) 81.262 (1) 102.260 (2)
𝛾 (deg) 74.382 (1) —
𝑉 (Å3) 831.59 (5) 2601.62 (18)




abs coeff (mm−1) 1.88 4.82
2𝜃max (deg) 135 66.2
𝑅[𝐹2 > 2𝜎(𝐹2)] 0.030 0.027
𝑤𝑅(𝐹2) 0.086 0.058
Res density 0.29, −0.41 1.50, −1.65
Data/parameters 2819/217 9917/354
Radiation type Cu 𝐾𝛼 Mo 𝐾𝛼



















































Figure 1: ORTEP plot of N(SO
2




pip)dpa)]+ (b). Thermal ellipsoids are drawn with 50%
probability.
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the opposite face of the octahedron are occupied by three
carbonyl ligands.
The distance of new bonds formed between Re and nitro-
gen atoms in dipicolylamine lies within the range of normal
values. Generally, the distance between Re and sp2 hybridized
nitrogen in a Re complex with prototypical NNN donor
ligand is 2.14–2.18 Å [4, 20]. The coordination bond between
Re and sp2 hybridized nitrogen in the pyridyl rings which
are denoted as N1 and N3 (Figure 1) exhibits a bond distance
close to that of the prototypical bond (Table 4). Similarly, the
coordination bond between Re and sp3 hybridized tertiary
nitrogen (2.251 (2) Å), though exceeding the normal range
(2.23–2.29 Å) [4, 20], is less than theRe–N2distance of 2.2826







rehybridization of sulfonamide nitrogen from sp2 to sp3 when
bound to Re. Further evidence for the rehybridization of
sulfonamide nitrogen from sp2 to sp3 upon binding to Re
is provided by the fact that the bond angles of this tertiary
sulfonamide nitrogen are closer to 109.5∘ (Table 5). All the







































other bond angles lie within the normal range of reported
compounds [5].







pip)dpa)]+ were characterized using
1H NMR spectroscopy in DMSO-𝑑
6
. Peaks related to
residual solvents were also identified [21, 22]. Signals related
to the dipicolylamine were assigned according to previously
reported data of related compounds [5, 23]. Protons attached
to the pyridyl nitrogen (H6/6󸀠) are more deshielded and
thereby signals are located downfield in the spectrum
(Figure 2). Protons in the piperidinyl ring were assigned
with the aid of reported spectra of related compounds
[10]. The signal for protons in the methylene groups of the
N(SO
2
pip)dpa appears as a singlet at (4.53 ppm) because
the protons attached to the two methylene groups are
magnetically equivalent due to free rotation. Singlet peaks
at 3.3, 2.5, 5.8, and 3.5 ppm are due to residual solvents
including water, DMSO, dichloromethane, and dioxane,
respectively [21, 22].
6 Bioinorganic Chemistry and Applications
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pip)dpa)]+, the methylene protons are pro-
jected towards and away from the carbonyl ligands attached
to rhenium and may be designated as endo-H and exo-H,
respectively.Therefore, thosemethylene protons are notmag-
netically equivalent. Hence, the singlet at 4.53 ppm related
to the CH
2
group of the free ligand appears as two doublets
further downfield upon binding to the metal (Figure 2). All
the signals related to protons attached to pyridyl nitrogen
have shifted downfield upon binding to the metal (Table 6).
These shifts of peaks may be attributed to the electron
withdrawing inductive effect as a result of the formation
of direct Re–N bond and provide strong evidence of the
formation of the metal complex.





pip)dpa)]+ may be attributed to MLCT
transition (Figure 3). Rhenium tricarbonyl complexes with
suitable ligands display MLCT transitions [24]. Other high
energy absorption peaks may be due to intraligand 𝜋 → 𝜋∗
and 𝑛 → 𝜋∗ transitions [24, 25].
3.4. FTIR Analysis. Literature has greatly aided in assigning
FTIR spectra of novel ligand and complex. In an FTIR
spectrum of N(SO
2
pip)dpa, a short absorption band appears
at 3077 cm−1 due to the asymmetric stretching vibration of
aliphatic systems [26]. A narrow and sharp absorption band
at 2942 cm−1 is attributed to the C–H asymmetric stretching
vibration of aliphatic systems [26]. A strong absorption band
at 1136 cm−1may be due to the symmetric stretching vibration
of S=O bond of the sulfonamide group [26]. A collection
of absorption peaks in the range between 1294 cm−1 and
1590 cm−1 is due to the symmetric and asymmetric stretching
vibrations of C=C bonds [26] in aromatic rings and C=N
stretching vibrationmode in the ligand [26]. Stretching vibra-
tion due to S–N bond is identified as the strong absorption
peak at 923 cm−1 [27].
Most of the peaks attributed to ligand also appear in a





in addition, two strong and intense absorption peaks at
2035 cm−1 and 1916 cm−1 are attributed to the stretching
vibrations of CO ligands in the Re(CO)
3
core [28]. C–N
stretching vibrations in the pyridyl rings have shifted towards
lower frequencies. S–N stretching vibration has shifted to a
lower frequency (836 cm−1) due to lowering of initial bond
energy resulting from the sigma donation of lone electron
pairs on sp3 hybridized orbital in sulfonamide nitrogen.








in methanol and acetonitrile. The concentrations of the test
samples were approximately 0.01mol/dm3. 3D scans were
Bioinorganic Chemistry and Applications 7
Table 6: Comparison of the 1H NMR shifts of N(SO
2




pip)dpa)]+ complex in DMSO-𝑑
6
.









pip)dpa)]+ 8.84 (d) 7.47 (t) 8.06 (t) 7.61 (d) 5.39 (d), 5.01 (d)






pip)dpa)]+ in methanol and acetonitrile.
Test sample Solvent Excitation wave length/nm Emission wave length/nm
N(SO
2






























done for the analysis and the relevant excitation and emission
details are summarized in Table 7.
N(SO
2
pip)dpa displays high fluorescence emission in
methanol and the intensity was enhanced even more in
acetonitrile (Figure 4). These emissions may occur due to
the intraligand 𝜋 → 𝜋∗ and 𝑛 → 𝜋∗ transitions. However,





lowered possibly due to the quenching of fluorescence upon
direct binding of sulfonamide nitrogen to the metal. Nev-





may arise due to the MLCT transition.
3.6. Antiproliferative Activity. Cytotoxicity in human breast
cancer cells (MCF-7) was induced upon addition of ligand
and complex at IC
50
of 139 𝜇M and 360 𝜇M, respectively,
after 24 hr (Figure 5). This shows that, comparatively, human
breast cancer cells show higher sensitivity to the ligand








ing novel compounds that can be further investigated on their
usage as anticancer agents and cancer cell imaging agents.
Comparisons of the IC
50
values obtained for ligand
and the complex at 24, 48, and 72 hr have shown that the
minimum test compound concentration needed to affect cell
viability increased with increasing incubation time (Table 8)
Table 8: IC
50
values reported for ligand and the complex at 24, 48,
and 72 hr incubation period.
Test compound IC50 values/𝜇M
24hr 48 hr 72 hr
Ligand 262 209 95
Complex 283 391 915
for the complex whereas it has decreased with that of the
ligand. This emphasizes that, comparatively, ligand cyto-
toxicity is much higher than the metal complex toxicity.
Decreasing cytotoxicity may be an indicator of activation of
repair mechanisms after the initial cellular damage.
Morphology of human breast cancer cells upon treating
with test compounds at 24, 48, and 72 hr time periods was
micrographed and images were obtained as in Figures 6 and
7.
Morphology of the cells does not show significant change
under light microscopy indicative of antiproliferative activity.
However, the cell numbers in wells have an apparent change.
Beside cytotoxic effects, the ligand shows an acute effect by
48 hours but numbers seem to be increasing by 72 hours.
Cells may have resorted to a repair mechanism against the
cytotoxic effect of the ligand. However, when complexed with
Re, the decline of cell population seems to be continuing
beyond 72 hr, which shows a persistent effect and continued
antiproliferative activity.
4. Conclusions
A novel ligand and its corresponding rhenium complex
were synthesized in good yield and purity and charac-
terized using single crystal X-ray diffraction, NMR, UV-
visible, and FTIR spectroscopy. The near-normal Re–N
bond lengths as well as the relatively long N–S bond
demonstrate that tertiary sulfonamide serves as a good





sp2 to sp3 rehybridization of sulfonamide nitrogen has





pip)dpa)]+ complex. The fluores-
cence of the free N(SO
2
pip)dpa ligand was quenched
upon direct binding of the sulfonamide nitrogen to Re
8 Bioinorganic Chemistry and Applications
Cell viability with complex (%)

























Figure 6: Morphology of human breast cancer cells (MCF-7), after 24, 48, and 72 hr incubating with the N(SO
2
pip)dpa ligand at increasing
concentrations.













pip)dpa)]+ was determined against human
breast cancer cells (MCF-7) by Sulforhodamine B assay.
Effects of complex on breast cancer cells seem to decrease
with time but the ligand continues to exert the cytotoxic effect
where both compounds show promising antiproliferative
activity.
In conclusion, utilizing the conjugation approach
described by Perera and coworkers [5], we demonstrate
that a piperidinyl group may be successfully introduced











to develop therapeutic and diagnostic agents because we
envisage that the synthesis reported here for nonradioactive
rhenium complexes may be extended to the 99mTc core.
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